Clinical Trial Update: Fosamax for Childhood Cancer Survivors [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating Fosamax (alendronate) for osteoporosis in childhood cancer survivors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• FOSAMAX (ALENDRONATE SODIUM)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Osteoporosis | Phase 3 | Status: UNKNOWN